I am trained as a pharmacist M.Sc. in Pharmacy from the University of Copenhagen and received a Ph.D. in pharmacoepidemiology from University of Southern Denmark.
My research focuses on the clinical epidemiology and use of in its broadest sense, with a current focus on inflammatory bowel disease, urogynaecology and assisted reproductive fertility treatment. My expertise is register-based research using clinical and national health registers.
Selected ongoing research
Does Disease Activity after induction Treatment with Anti–Tumor Necrosis Factor, Predict Short-Term Outcomes in Crohn’s Disease and Ulcerative Colitis?
How does disease control versus maintenance treatment strategy affect the prognostic impact of disease activity and the tolerance of anti-tumor necrosis factors?
Infertility treatment in women with chronic disease reproductive outcomes in women with inflammatory bowel disease.
Jolving LR, Larsen MD, Fedder J, Friedman S, Norgard BM. The chance of a live birth after assisted reproduction in women with thyroid disorders. Clin Epidemiol. 2019;11:683-94.
Lund K, Larsen MD, Knudsen T, Kjeldsen J, Nielsen RG, Norgard BM. The impact of anti-TNFalpha therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis-a nationwide study from 1995 to 2015. Aliment Pharmacol Ther. 2019;50(10):1077-85. (Impact factor 7.7)
Husby KR, Larsen MD, Lose G, Klarskov N. Surgical treatment of primary uterine prolapse: a comparison of vaginal native tissue surgical techniques. International urogynecology journal. 2019.
Korzenik J, Larsen MD, Nielsen J, Kjeldsen J, Norgard BM. Editorial: anti-TNF therapy-a double-edged sword? Authors' reply. Aliment Pharmacol Ther. 2019;50(7):823-4.
Korzenik J, Larsen MD, Nielsen J, Kjeldsen J, Nørgård BM. Increased risk of developing Crohn’s disease or ulcerative colitis in 17 018 patients while under treatment with anti TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease. Aliment Pharmacol Ther. 2019;00:1-6. (Impact factor 7.7)
Norgard BM, Larsen MD, Friedman S, Knudsen T, Fedder J. Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study. Annals of the rheumatic diseases. 2019;78(3):328-34. (Impact factor 12.3)
Norgard BM, Jolving LR, Larsen MD, Friedman S. Parental IBD and Long-term Health Outcomes in the Offspring. Inflamm Bowel Dis. 2019;25(8):1339-48 (Impact factor 4.34)
Larsen MD, Guldberg R, Lose G. Perioperative cardiovascular complications following urogynecological operations. Acta obstetricia et gynecologica Scandinavica. 2019;98(1):61-7.
Strehlau AG, Larsen MD, Sondergaard J, Almarsdottir AB, Rosholm JU. General practitioners' continuation and acceptance of medication changes at sectorial transitions of geriatric patients - a qualitative interview study. BMC family practice. 2018;19(1):168.
Friedman S, Magnussen B, O'Toole A, Fedder J, Larsen MD, Norgard BM. Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study. The American journal of gastroenterology. 2018. (Impact factor 10.2)
Weltz V, Guldberg R, Larsen MD, Magnussen B, Lose G. Influence of body mass index on short-term subjective improvement and risk of reoperation after mid-urethral sling surgery. International urogynecology journal. 2018;29(4):585-591.
Larsen MD, Friedman S, Magnussen B, Norgard BM. Birth Outcomes of Children Fathered by Men Treated with Systemic Corticosteroids during the Conception Period - A Cohort Study based on Nationwide Data. Basic Clin Pharmacol Toxicol. 2017.
Se CV for full list of puplications